MAPT and Dravet syndrome: Imaging studies support that plasma t‐tau concentrations in amyloid PET–positive DS individuals, regardless of whether they are tau PET negative or tau PET positive, showed significant differences compared to amyloid and tau PET–negative DS individuals.59